TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs258324
log Bayes Factor = 0.0699307
Chromosome 16   position 89,754,255  (GRCh37) Explore rs258324 on Ensembl!
Variant rs258324 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C44.5 Skin of trunk
0.181 0.819 0.000
C44 Other malignant neoplasms of skin
0.178 0.822 0.000
C44.0 Skin of lip
0.167 0.833 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.159 0.841 0.000
C43 Malignant melanoma of skin
0.158 0.842 0.000
C44.2 Skin of ear and external auricular canal
0.155 0.845 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.155 0.845 0.000
C44.1 Skin of eyelid, including canthus
0.147 0.853 0.000
C44.7 Skin of lower limb, including hip
0.138 0.862 0.000
C44.3 Skin of other and unspecified parts of face
0.134 0.866 0.000
C43.7 Malignant melanoma of lower limb, including hip
0.130 0.870 0.000
C44.8 Overlapping lesion of skin
0.127 0.872 0.000
C43.5 Malignant melanoma of trunk
0.123 0.877 0.000
C44.6 Skin of upper limb, including shoulder
0.121 0.879 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.119 0.880 0.000
C43.9 Malignant melanoma of skin, unspecified
0.116 0.884 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.115 0.885 0.000
C43.0 Malignant melanoma of lip
0.114 0.886 0.000
C43.8 Overlapping malignant melanoma of skin
0.113 0.887 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.111 0.889 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.107 0.893 0.000
C43.4 Malignant melanoma of scalp and neck
0.088 0.912 0.000
C44.4 Skin of scalp and neck
0.027 0.973 0.000
F60.3 Emotionally unstable personality disorder
0.000 0.979 0.021
F60 Specific personality disorders
0.000 0.980 0.020
F60.9 Personality disorder, unspecified
0.000 0.982 0.018
F60.0 Paranoid personality disorder
0.000 0.983 0.017
N18 Chronic renal failure
0.016 0.984 0.000
N18.0 End-stage renal disease
0.016 0.984 0.000
N18.9 Chronic renal failure, unspecified
0.015 0.985 0.000
F60-F69 Disorders of adult personality and behaviour
0.000 0.985 0.015
F60.6 Anxious [avoidant] personality disorder
0.000 0.986 0.014
F60.4 Histrionic personality disorder
0.000 0.986 0.014
F60.1 Schizoid personality disorder
0.000 0.986 0.014
F60.5 Anankastic personality disorder
0.000 0.986 0.014
F60.2 Dissocial personality disorder
0.000 0.986 0.014
N18.5 Chronic kidney disease, stage 5
0.014 0.986 0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts
0.000 0.986 0.014
N18.4 Chronic kidney disease, stage 4
0.014 0.986 0.000
F69 Unspecified disorder of adult personality and behaviour
0.000 0.987 0.013
F60.7 Dependent personality disorder
0.000 0.987 0.013
F60.8 Other specific personality disorders
0.000 0.987 0.013
N18.8 Other chronic renal failure
0.013 0.987 0.000
N18.3 Chronic kidney disease, stage 3
0.012 0.988 0.000
N18.1 Chronic kidney disease, stage 1
0.012 0.988 0.000
F64 Gender identity disorders
0.000 0.988 0.012
F61 Mixed and other personality disorders
0.000 0.988 0.012
Z09.0 Follow-up examination after surgery for other conditions
0.012 0.988 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.000 0.989 0.011
F65 Disorders of sexual preference
0.000 0.989 0.011
F63 Habit and impulse disorders
0.000 0.989 0.011
F68 Other disorders of adult personality and behaviour
0.000 0.989 0.011
F62 Enduring personality changes, not attributable to brain damage and disease
0.000 0.989 0.010
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.990 0.010
N18.2 Chronic kidney disease, stage 2
0.010 0.990 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.990 0.010
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.990 0.010
F64.0 Transsexualism
0.000 0.990 0.010
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.991 0.009
T39.0 Salicylates
0.000 0.991 0.009
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.991 0.009
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.991 0.009
T45.0 Antiallergic and antiemetic drugs
0.000 0.991 0.009
F64.9 Gender identity disorder, unspecified
0.000 0.991 0.009
F64.8 Other gender identity disorders
0.000 0.991 0.009
F64.2 Gender identity disorder of childhood
0.000 0.991 0.009
F64.1 Dual-role transvestism
0.000 0.991 0.009
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.992 0.008
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.992 0.008
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.992 0.008
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.992 0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.992 0.008
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.992 0.008
T45.2 Vitamins, not elsewhere classified
0.000 0.992 0.008
F63.9 Habit and impulse disorder, unspecified
0.000 0.992 0.008
F63.8 Other habit and impulse disorders
0.000 0.992 0.008
F63.3 Trichotillomania
0.000 0.992 0.008
F63.2 Pathological stealing [kleptomania]
0.000 0.992 0.008
F63.1 Pathological fire-setting [pyromania]
0.000 0.992 0.008
F63.0 Pathological gambling
0.000 0.992 0.008
F65.9 Disorder of sexual preference, unspecified
0.000 0.992 0.008
F65.8 Other disorders of sexual preference
0.000 0.992 0.008
F65.6 Multiple disorders of sexual preference
0.000 0.992 0.008
F65.5 Sadomasochism
0.000 0.992 0.008
F65.4 Paedophilia
0.000 0.992 0.008
F65.3 Voyeurism
0.000 0.992 0.008
F65.2 Exhibitionism
0.000 0.992 0.008
F65.1 Fetishistic transvestism
0.000 0.992 0.008
F65.0 Fetishism
0.000 0.992 0.008
F66.9 Psychosexual development disorder, unspecified
0.000 0.992 0.008
F66.8 Other psychosexual development disorders
0.000 0.992 0.008
F66.2 Sexual relationship disorder
0.000 0.992 0.008
F66.1 Egodystonic sexual orientation
0.000 0.992 0.008
F66.0 Sexual maturation disorder
0.000 0.992 0.008
F68.8 Other specified disorders of adult personality and behaviour
0.000 0.992 0.008
F68.0 Elaboration of physical symptoms for psychological reasons
0.000 0.992 0.008
M17.9 Gonarthrosis, unspecified
0.008 0.992 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.992 0.008
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.000 0.992 0.008
F62.8 Other enduring personality changes
0.000 0.992 0.008
F62.1 Enduring personality change after psychiatric illness
0.000 0.992 0.008
F62.0 Enduring personality change after catastrophic experience
0.000 0.992 0.008
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.992 0.008
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.992 0.008
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.992 0.008
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.992 0.008
T44.0 Anticholinesterase agents
0.000 0.992 0.008
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.992 0.007
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.992 0.007
F62.9 Enduring personality change, unspecified
0.000 0.992 0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.992 0.007
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.992 0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.993 0.007
H40.2 Primary angle-closure glaucoma
0.007 0.993 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.993 0.007
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.993 0.007
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.993 0.007
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.993 0.007
T46.1 Calcium-channel blockers
0.000 0.993 0.007
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.993 0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.993 0.007
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.993 0.007
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.993 0.007
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.993 0.007
T39.4 Antirheumatics, not elsewhere classified
0.000 0.993 0.007
T39.2 Pyrazolone derivatives
0.000 0.993 0.007
T39.1 4-Aminophenol derivatives
0.000 0.993 0.007
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.993 0.007
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.993 0.007
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.993 0.007
T45.8 Other primarily systemic and haematological agents
0.000 0.993 0.007
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.993 0.007
T45.6 Fibrinolysis-affecting drugs
0.000 0.993 0.007
T45.3 Enzymes, not elsewhere classified
0.000 0.993 0.007
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.993 0.007
T46.7 Peripheral vasodilators
0.000 0.993 0.007
T45.5 Anticoagulants
0.000 0.993 0.007
N17-N19 Renal failure
0.007 0.993 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.993 0.007
H40.8 Other glaucoma
0.007 0.993 0.000
T47.6 Antidiarrhoeal drugs
0.000 0.993 0.007
H40 Glaucoma
0.007 0.993 0.000
K82.9 Disease of gallbladder, unspecified
0.000 0.993 0.007
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.993 0.006
T50.1 Loop [high-ceiling] diuretics
0.000 0.993 0.006
T45.4 Iron and its compounds
0.000 0.993 0.006
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.993 0.006
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.994 0.006
T47.4 Other laxatives
0.000 0.994 0.006
H40.1 Primary open-angle glaucoma
0.006 0.994 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.994 0.006
T38.7 Androgens and anabolic congeners
0.000 0.994 0.006
T38.4 Oral contraceptives
0.000 0.994 0.006
T38.2 Antithyroid drugs
0.000 0.994 0.006
T50.7 Analeptics and opioid receptor antagonists
0.000 0.994 0.006
T50.5 Appetite depressants
0.000 0.994 0.006
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.994 0.006
T50.0 Mineralocorticoids and their antagonists
0.000 0.994 0.006
T38.1 Thyroid hormones and substitutes
0.000 0.994 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.994 0.006
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.994 0.006
T47.7 Emetics
0.000 0.994 0.006
T47.5 Digestants
0.000 0.994 0.006
T47.3 Saline and osmotic laxatives
0.000 0.994 0.006
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.006
T38.5 Other oestrogens and progestogens
0.000 0.994 0.006
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.994 0.006
T47.2 Stimulant laxatives
0.000 0.994 0.006
T49.9 Topical agent, unspecified
0.000 0.994 0.006
T49.8 Other topical agents
0.000 0.994 0.006
T49.7 Dental drugs, topically applied
0.000 0.994 0.006
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.994 0.006
T49.5 Ophthalmological drugs and preparations
0.000 0.994 0.006
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.994 0.006
T49.3 Emollients, demulcents and protectants
0.000 0.994 0.006
T49.2 Local astringents and local detergents
0.000 0.994 0.006
T49.1 Antipruritics
0.000 0.994 0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.994 0.006
T38.0 Glucocorticoids and synthetic analogues
0.000 0.994 0.006
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.006
N19 Unspecified renal failure
0.006 0.994 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.994 0.006
T47.0 Histamine H(2)-receptor antagonists
0.000 0.994 0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.994 0.005
T37.5 Antiviral drugs
0.000 0.994 0.005
T37.4 Anthelminthics
0.000 0.994 0.005
T37.3 Other antiprotozoal drugs
0.000 0.994 0.005
T37.1 Antimycobacterial drugs
0.000 0.994 0.005
T37.0 Sulphonamides
0.000 0.994 0.005
T50.8 Diagnostic agents
0.000 0.994 0.005
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.994 0.005
T48.4 Expectorants
0.000 0.994 0.005
T48.3 Antitussives
0.000 0.994 0.005
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.994 0.005
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.994 0.005
T48.0 Oxytocic drugs
0.000 0.994 0.005
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.994 0.005
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
T41.5 Therapeutic gases
0.000 0.995 0.005
T41.4 Anaesthetic, unspecified
0.000 0.995 0.005
T41.3 Local anaesthetics
0.000 0.995 0.005
T41.1 Intravenous anaesthetics
0.000 0.995 0.005
T41.0 Inhaled anaesthetics
0.000 0.995 0.005
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
H40.6 Glaucoma secondary to drugs
0.005 0.995 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
T48.5 Anti-common-cold drugs
0.000 0.995 0.005
H40.5 Glaucoma secondary to other eye disorders
0.005 0.995 0.000
H40.3 Glaucoma secondary to eye trauma
0.005 0.995 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.005
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.995 0.005
T41.2 Other and unspecified general anaesthetics
0.000 0.995 0.005
L57.0 Actinic keratosis
0.005 0.995 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.995 0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.995 0.005
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.995 0.005
T42.4 Benzodiazepines
0.000 0.995 0.005
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.005 0.995 0.000
T43.6 Psychostimulants with abuse potential
0.000 0.995 0.005
T43.2 Other and unspecified antidepressants
0.000 0.995 0.005
H40.4 Glaucoma secondary to eye inflammation
0.005 0.995 0.000
T42.1 Iminostilbenes
0.000 0.995 0.005
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.995 0.004
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.995 0.004
T42.2 Succinimides and oxazolidinediones
0.000 0.995 0.004
H40.9 Glaucoma, unspecified
0.005 0.995 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.996 0.004
T42.3 Barbiturates
0.000 0.996 0.004
N05 Unspecified nephritic syndrome
0.004 0.996 0.000
N05.9 Unspecified
0.004 0.996 0.000
N17 Acute renal failure
0.004 0.996 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.000 0.996 0.004
N05.1 Focal and segmental glomerular lesions
0.004 0.996 0.000
G25.0 Essential tremor
0.004 0.996 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T42.0 Hydantoin derivatives
0.000 0.996 0.004
N08.3 Glomerular disorders in diabetes mellitus
0.004 0.996 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.996 0.004
N05.8 Other
0.004 0.996 0.000
H40.0 Glaucoma suspect
0.004 0.996 0.000
T36.3 Macrolides
0.000 0.996 0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.996 0.004
N08 Glomerular disorders in diseases classified elsewhere
0.004 0.996 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.996 0.004
T40.8 Lysergide [LSD]
0.000 0.996 0.004
T40.7 Cannabis (derivatives)
0.000 0.996 0.004
T40.0 Opium
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.003
T40.1 Heroin
0.000 0.996 0.004
Z60.2 Living alone
0.004 0.996 0.000
T40.2 Other opioids
0.000 0.996 0.004
E89.0 Postprocedural hypothyroidism
0.004 0.996 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.004 0.996 0.000
K81.0 Acute cholecystitis
0.000 0.996 0.004
T40.4 Other synthetic narcotics
0.000 0.996 0.003
N03 Chronic nephritic syndrome
0.004 0.996 0.000
N00-N08 Glomerular diseases
0.004 0.996 0.000
T40.3 Methadone
0.000 0.996 0.003
T40.5 Cocaine
0.000 0.996 0.003
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.996 0.000
N05.7 Diffuse crescentic glomerulonephritis
0.003 0.996 0.000
N03.9 Unspecified
0.003 0.997 0.000
N17.1 Acute renal failure with acute cortical necrosis
0.003 0.997 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.000 0.997 0.003
N05.6 Dense deposit disease
0.003 0.997 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N05.0 Minor glomerular abnormality
0.003 0.997 0.000
T36.0 Penicillins
0.001 0.997 0.003
N17.8 Other acute renal failure
0.003 0.997 0.000
K55.9 Vascular disorder of intestine, unspecified
0.003 0.997 0.000
N17.2 Acute renal failure with medullary necrosis
0.003 0.997 0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh
0.003 0.997 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.003 0.997 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.003 0.997 0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm
0.000 0.997 0.003
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.003 0.997 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.003 0.997 0.000
N17.0 Acute renal failure with tubular necrosis
0.003 0.997 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.003 0.997 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
N03.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.003 0.997 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.003 0.997 0.000
N04 Nephrotic syndrome
0.003 0.997 0.000
N03.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N00 Acute nephritic syndrome
0.003 0.997 0.000
Z33 Pregnant state, incidental
0.000 0.997 0.003
H40-H42 Glaucoma
0.003 0.997 0.000
N05.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N03.8 Other
0.003 0.997 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N03.6 Dense deposit disease
0.003 0.997 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N03.0 Minor glomerular abnormality
0.003 0.997 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.003 0.997 0.000
N06 Isolated proteinuria with specified morphological lesion
0.003 0.997 0.000
N01 Rapidly progressive nephritic syndrome
0.003 0.997 0.000
M79.89 Other specified soft tissue disorders (Site unspecified)
0.000 0.997 0.003
T40.6 Other and unspecified narcotics
0.000 0.997 0.002
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
R44.0 Auditory hallucinations
0.000 0.997 0.003
C16.0 Cardia
0.000 0.997 0.003
I72.8 Aneurysm of other specified arteries
0.003 0.997 0.000
R00.0 Tachycardia, unspecified
0.003 0.997 0.000
I72 Other aneurysm
0.003 0.997 0.000
I72.4 Aneurysm of artery of lower extremity
0.003 0.997 0.000
K55.0 Acute vascular disorders of intestine
0.003 0.997 0.000
F20.9 Schizophrenia, unspecified
0.000 0.997 0.003
I72.0 Aneurysm of carotid artery
0.003 0.997 0.000
K13.0 Diseases of lips
0.000 0.997 0.003
N04.9 Unspecified
0.003 0.997 0.000
K76.0 Fatty (change of) liver, not elsewhere classified
0.003 0.997 0.000
I71 Aortic aneurysm and dissection
0.003 0.997 0.000
G25.8 Other specified extrapyramidal and movement disorders
0.003 0.997 0.000
N21.0 Calculus in bladder
0.003 0.997 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.003 0.997 0.000
M06.9 Rheumatoid arthritis, unspecified
0.003 0.997 0.000
N04.8 Other
0.002 0.997 0.000
K13.7 Other and unspecified lesions of oral mucosa
0.000 0.997 0.003
N04.1 Focal and segmental glomerular lesions
0.002 0.997 0.000
C67.9 Bladder, unspecified
0.000 0.997 0.003
M47.92 Spondylosis, unspecified (Cervical region)
0.000 0.998 0.002
R16.1 Splenomegaly, not elsewhere classified
0.000 0.998 0.002
Z85.5 Personal history of malignant neoplasm of urinary tract
0.000 0.998 0.002
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
I72.1 Aneurysm of artery of upper extremity
0.002 0.998 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N04.6 Dense deposit disease
0.002 0.998 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N00.9 Unspecified
0.002 0.998 0.000
N00.8 Other
0.002 0.998 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N00.6 Dense deposit disease
0.002 0.998 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N00.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
N00.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
N00.0 Minor glomerular abnormality
0.002 0.998 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.002 0.998 0.000
G25 Other extrapyramidal and movement disorders
0.002 0.998 0.000
H42 Glaucoma in diseases classified elsewhere
0.002 0.998 0.000
E89.3 Postprocedural hypopituitarism
0.002 0.998 0.000
N01.9 Unspecified
0.002 0.998 0.000
N01.8 Other
0.002 0.998 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N01.6 Dense deposit disease
0.002 0.998 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N01.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
N01.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
N01.0 Minor glomerular abnormality
0.002 0.998 0.000
N06.9 Unspecified
0.002 0.998 0.000
N06.8 Other
0.002 0.998 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N06.6 Dense deposit disease
0.002 0.998 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N06.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
N06.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
N06.0 Minor glomerular abnormality
0.002 0.998 0.000
N07.9 Unspecified
0.002 0.998 0.000
N07.8 Other
0.002 0.998 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N07.6 Dense deposit disease
0.002 0.998 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N07.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
N07.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
N07.0 Minor glomerular abnormality
0.002 0.998 0.000
Z60 Problems related to social environment
0.002 0.998 0.000
I72.9 Aneurysm of unspecified site
0.002 0.998 0.000
I71.1 Thoracic aortic aneurysm, ruptured
0.002 0.998 0.000
N04.0 Minor glomerular abnormality
0.002 0.998 0.000
N04.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
K55 Vascular disorders of intestine
0.002 0.998 0.000
F22.0 Delusional disorder
0.000 0.998 0.002
I72.6 Aneurysm and dissection of vertebral artery
0.002 0.998 0.000
I72.5 Aneurysm and dissection of other precerebral arteries
0.002 0.998 0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa
0.000 0.998 0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.002 0.998 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
0.002 0.998 0.000
K13 Other diseases of lip and oral mucosa
0.000 0.998 0.002
S02.10 Fracture of base of skull (closed)
0.000 0.998 0.002
I71.8 Aortic aneurysm of unspecified site, ruptured
0.002 0.998 0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.002 0.998 0.000
Q05.9 Spina bifida, unspecified
0.002 0.998 0.000
E89.5 Postprocedural testicular hypofunction
0.002 0.998 0.000
G25.1 Drug-induced tremor
0.002 0.998 0.000
Z60.8 Other problems related to social environment
0.002 0.998 0.000
F20 Schizophrenia
0.000 0.998 0.002
M06.98 Rheumatoid arthritis, unspecified (Other)
0.002 0.998 0.000
E89.2 Postprocedural hypoparathyroidism
0.002 0.998 0.000
I72.2 Aneurysm of renal artery
0.002 0.998 0.000
T92.1 Sequelae of fracture of arm
0.000 0.998 0.002
E89.8 Other postprocedural endocrine and metabolic disorders
0.002 0.998 0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.002 0.998 0.000
Z60.9 Problem related to social environment, unspecified
0.002 0.998 0.000
I74 Arterial embolism and thrombosis
0.002 0.998 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.002 0.998 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.002 0.998 0.000
K55.8 Other vascular disorders of intestine
0.002 0.998 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.002 0.998 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.002 0.998 0.000
G25.6 Drug-induced tics and other tics of organic origin
0.002 0.998 0.000
G25.4 Drug-induced chorea
0.002 0.998 0.000
H42.8 Glaucoma in other diseases classified elsewhere
0.002 0.998 0.000
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases
0.002 0.998 0.000
M17 Gonarthrosis [arthrosis of knee]
0.002 0.998 0.000
I71.0 Dissection of aorta [any part]
0.002 0.998 0.000
I74.8 Embolism and thrombosis of other arteries
0.002 0.998 0.000
Z60.5 Target of perceived adverse discrimination and persecution
0.002 0.998 0.000
Z60.4 Social exclusion and rejection
0.002 0.998 0.000
Z60.3 Acculturation difficulty
0.002 0.998 0.000
Z60.1 Atypical parenting situation
0.002 0.998 0.000
Z60.0 Problems of adjustment to life-cycle transitions
0.002 0.998 0.000
F22 Persistent delusional disorders
0.000 0.998 0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.002 0.998 0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.002 0.998 0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.000 0.998 0.002
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.002 0.998 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.002 0.998 0.000
M17.0 Primary gonarthrosis, bilateral
0.002 0.998 0.000
E89.1 Postprocedural hypoinsulinaemia
0.002 0.998 0.000
N17.9 Acute renal failure, unspecified
0.002 0.998 0.000
E89.4 Postprocedural ovarian failure
0.002 0.998 0.000
K65.8 Other peritonitis
0.002 0.998 0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.002 0.998 0.000
N02 Recurrent and persistent haematuria
0.002 0.998 0.000
I70-I79 Diseases of arteries, arterioles and capillaries
0.002 0.998 0.000
F20.8 Other schizophrenia
0.000 0.998 0.002
G25.2 Other specified forms of tremor
0.002 0.998 0.000
M17.2 Posttraumatic gonarthrosis, bilateral
0.002 0.998 0.000
L57.3 Poikiloderma of Civatte
0.002 0.998 0.000
L57.2 Cutis rhomboidalis nuchae
0.002 0.998 0.000
L57.1 Actinic reticuloid
0.002 0.998 0.000
X60.2 School, other institution and public administrative area
0.000 0.998 0.002
I71.3 Abdominal aortic aneurysm, ruptured
0.002 0.998 0.000
I72.3 Aneurysm of iliac artery
0.002 0.998 0.000
K13.5 Oral submucous fibrosis
0.000 0.998 0.002
M70.6 Trochanteric bursitis
0.002 0.998 0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified
0.002 0.998 0.000
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue
0.000 0.998 0.002
K13.3 Hairy leukoplakia
0.000 0.998 0.002
R60.9 Oedema, unspecified
0.000 0.998 0.002
I70 Atherosclerosis
0.002 0.998 0.000
D03.5 Melanoma in situ of trunk
0.002 0.998 0.000
G25.5 Other chorea
0.002 0.998 0.000
K13.1 Cheek and lip biting
0.000 0.998 0.002
U51.1 Previously admitted to a psychiatric hospital of the provider
0.000 0.998 0.002
I74.5 Embolism and thrombosis of iliac artery
0.002 0.998 0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta
0.002 0.998 0.000
K55.1 Chronic vascular disorders of intestine
0.002 0.998 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.002 0.998 0.000
I70.10 Atherosclerosis of renal artery (without gangrene)
0.002 0.998 0.000
I70.1 Atherosclerosis of renal artery
0.002 0.998 0.000
I70.0 Atherosclerosis of aorta
0.002 0.998 0.000
L57.5 Actinic granuloma
0.002 0.998 0.000
F20.6 Simple schizophrenia
0.000 0.998 0.002
F20.4 Postschizophrenic depression
0.000 0.998 0.002
F20.3 Undifferentiated schizophrenia
0.000 0.998 0.002
F20.1 Hebephrenic schizophrenia
0.000 0.998 0.002
L85.9 Epidermal thickening, unspecified
0.002 0.998 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.000 0.998 0.002
R16.0 Hepatomegaly, not elsewhere classified
0.002 0.998 0.000
X63.0 Home
0.000 0.998 0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.002 0.998 0.000
M17.4 Other secondary gonarthrosis, bilateral
0.002 0.998 0.000
F29 Unspecified nonorganic psychosis
0.000 0.998 0.002
F20.2 Catatonic schizophrenia
0.000 0.998 0.002
K56.2 Volvulus
0.000 0.998 0.002
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.002 0.998 0.000
F22.8 Other persistent delusional disorders
0.000 0.998 0.002
G25.3 Myoclonus
0.002 0.998 0.000
L57.4 Cutis laxa senilis
0.001 0.998 0.000
N02.8 Other
0.002 0.998 0.000
F20.5 Residual schizophrenia
0.000 0.998 0.001
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.002 0.998 0.000
I74.0 Embolism and thrombosis of abdominal aorta
0.002 0.998 0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.000 0.998 0.002
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.998 0.002
D03.3 Melanoma in situ of other and unspecified parts of face
0.002 0.998 0.000
F22.9 Persistent delusional disorder, unspecified
0.000 0.998 0.001
I79.2 Peripheral angiopathy in diseases classified elsewhere
0.002 0.998 0.000
J30.1 Allergic rhinitis due to pollen
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.